Resveratrol Nanoformulations for Cancer Management: A Comprehensive Review of Disease-Specific Strategies and Clinical Translational Barriers
International Journal of Nanomedicine · 2026
DOI: 10.2147/ijn.s610050 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Nanomedicine, 2026. Verfasst von Huifang Yang und 5 weiteren Autor:innen. Beteiligte Einrichtung: Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu, Sichuan, People's Republic of China. Hauptthemen laut MEDLINE: Resveratrol, Neoplasms, Nanoparticle Drug Delivery System, Stilbenes. Die Arbeit wurde bisher 1-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu, Sichuan, People's Republic of China.
ORCID-Profile: Huifang Yang, Yilin Wang
Zitieren
APA
Yang, H., Cheng, Z., Wang, Y., Tang, K., Zeng, T., & Guo, J. (2026). Resveratrol Nanoformulations for Cancer Management: A Comprehensive Review of Disease-Specific Strategies and Clinical Translational Barriers. International Journal of Nanomedicine. https://doi.org/10.2147/ijn.s610050
Vancouver
Yang H, Cheng Z, Wang Y, Tang K, Zeng T, Guo J. Resveratrol Nanoformulations for Cancer Management: A Comprehensive Review of Disease-Specific Strategies and Clinical Translational Barriers. International Journal of Nanomedicine. 2026. doi:10.2147/ijn.s610050
BibTeX
@article{Yang2026,
author = {Yang, Huifang and Cheng, Zilin and Wang, Yilin and Tang, Kexin and Zeng, Tongtong and Guo, Jing},
title = {Resveratrol Nanoformulations for Cancer Management: A Comprehensive Review of Disease-Specific Strategies and Clinical Translational Barriers},
journal = {International Journal of Nanomedicine},
year = {2026},
doi = {10.2147/ijn.s610050}
}
EUVIMED